Monashee Investment Management »

Nuvation Bio shares owned by Monashee Investment Management

Quarter-by-quarter ownership of Nuvation Bio shares owned by Monashee Investment Management from 13F filings

Historical chart of Monashee Investment Management investment in Nuvation Bio

Tip: Access up to 7 years of quarterly data

All positions including Nuvation Bio held by Monashee Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nuvation Bio by Monashee Investment Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.1M 1.0M 1.06

More positions owned by Monashee Investment Management

Alphabet Dep Shs Rp1/20 A
Alphabet Dep Shs Rp1/20 B
Solid Biosciences Com New (SLDB)
Digital Realty Trust (DLR)
Spyre Therapeutics Com New (SYRE)
Adt (ADT)
Tango Therapeutics (TNGX)
Celcuity Note 0.250% 8/0 (Principal)
Super Micro Computer 7 Dep Cm Sr A Wi
Legend Biotech Corp Sponsored Ads (LEGN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Uniqure Nv SHS (QURE)
Innio Nv Ordinary Shares
Acadia Rlty Tr Com Sh Ben Int (AKR)

View all positions for Monashee Investment Management

Top funds holding Nuvation Bio

Linden Advisors
Context Capital Management
D. E. Shaw & Co
Polar Securities
Tenor Capital Management
Citadel Advisors
Leucadia National Corporation
Advent Capital Management
Millennium Management
Jane Street
QVT Financial
Lazard Asset Management
BlackRock
Susquehanna Advisors Group
Readystate Asset Management

View all funds holding Nuvation Bio